Helfrich W - Search Results

1

Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.

Lütje S, van Rij CM, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC. Lütje S, et al. Among authors: helfrich w. Contrast Media Mol Imaging. 2015 Jan-Feb;10(1):28-36. doi: 10.1002/cmmi.1596. Epub 2014 Apr 25. Contrast Media Mol Imaging. 2015. PMID: 24764162 Free article.

2

Prospects in radionuclide imaging of prostate cancer.

Lütje S, Boerman OC, van Rij CM, Sedelaar M, Helfrich W, Oyen WJ, Mulders PF. Lütje S, et al. Among authors: helfrich w. Prostate. 2012 Aug 1;72(11):1262-72. doi: 10.1002/pros.22462. Epub 2011 Nov 29. Prostate. 2012. PMID: 22127918 Review.

3

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.

Lütje S, Rijpkema M, Franssen GM, Fracasso G, Helfrich W, Eek A, Oyen WJ, Colombatti M, Boerman OC. Lütje S, et al. Among authors: helfrich w. J Nucl Med. 2014 Jun;55(6):995-1001. doi: 10.2967/jnumed.114.138180. Epub 2014 Apr 3. J Nucl Med. 2014. PMID: 24700882 Free article.

4

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

Lütje S, Rijpkema M, Helfrich W, Oyen WJ, Boerman OC. Lütje S, et al. Among authors: helfrich w. Mol Imaging Biol. 2014 Dec;16(6):747-55. doi: 10.1007/s11307-014-0747-y. Mol Imaging Biol. 2014. PMID: 24849133 Review.

5

Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.

Lütje S, Rijpkema M, Goldenberg DM, van Rij CM, Sharkey RM, McBride WJ, Franssen GM, Frielink C, Helfrich W, Oyen WJ, Boerman OC. Lütje S, et al. Among authors: helfrich w. Cancer Res. 2014 Nov 1;74(21):6216-23. doi: 10.1158/0008-5472.CAN-14-0594. Epub 2014 Sep 24. Cancer Res. 2014. PMID: 25252911

6

Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.

Yu Z, Carlucci G, Ananias HJ, Dierckx RA, Liu S, Helfrich W, Wang F, de Jong IJ, Elsinga PH. Yu Z, et al. Among authors: helfrich w. Amino Acids. 2013 Feb;44(2):543-53. doi: 10.1007/s00726-012-1369-9. Epub 2012 Jul 26. Amino Acids. 2013. PMID: 22833158

7

GRPR-selective PET imaging of prostate cancer using [(18)F]-lanthionine-bombesin analogs.

Carlucci G, Kuipers A, Ananias HJ, de Paula Faria D, Dierckx RA, Helfrich W, Rink R, Moll GN, de Jong IJ, Elsinga PH. Carlucci G, et al. Among authors: helfrich w. Peptides. 2015 May;67:45-54. doi: 10.1016/j.peptides.2015.03.004. Epub 2015 Mar 20. Peptides. 2015. PMID: 25797109

8

Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.

Amoury M, Kolberg K, Pham AT, Hristodorov D, Mladenov R, Di Fiore S, Helfrich W, Kiessling F, Fischer R, Pardo A, Thepen T, Hussain AF, Nachreiner T, Barth S. Amoury M, et al. Among authors: helfrich w. Cancer Lett. 2016 Mar 28;372(2):201-9. doi: 10.1016/j.canlet.2016.01.027. Epub 2016 Jan 21. Cancer Lett. 2016. PMID: 26806809

9

Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of ¹⁸ F-Labeled PSMA-Tracers for Prostate Cancer Imaging.

Böhmer VI, Szymanski W, van den Berg KO, Mulder C, Kobauri P, Helbert H, van der Born D, Reeβing F, Huizing A, Klopstra M, Samplonius DF, Antunes IF, Sijbesma JWA, Luurtsema G, Helfrich W, Visser TJ, Feringa BL, Elsinga PH. Böhmer VI, et al. Among authors: helfrich w. Chemistry. 2020 Aug 21;26(47):10871-10881. doi: 10.1002/chem.202001795. Epub 2020 Jul 21. Chemistry. 2020. PMID: 32315486 Free PMC article.

10

A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments.

Huls GA, Heijnen IA, Cuomo ME, Koningsberger JC, Wiegman L, Boel E, van der Vuurst de Vries AR, Loyson SA, Helfrich W, van Berge Henegouwen GP, van Meijer M, de Kruif J, Logtenberg T. Huls GA, et al. Among authors: helfrich w. Nat Biotechnol. 1999 Mar;17(3):276-81. doi: 10.1038/7023. Nat Biotechnol. 1999. PMID: 10096296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page